Susanna Roberts

Susanna Roberts

Auto-generated profile, based on publicly available information

Susanna Roberts

Institute of Psychiatry, Psychology & Neuroscience

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Psychiatry Research
Verified
Journal Article
Open access
SRSusanna Roberts
Susanna Roberts
LALouise Arseneault
Louise Arseneault
BBBenjamin Barratt
Benjamin Barratt
SBSean Beevers
Sean Beevers
ADAndrea Danese
Andrea Danese
HFHelen L. Fisher
Helen L. Fisher
Air pollution is a worldwide environmental health issue. Increasingly, reports suggest that poor air quality may be associated with mental health problems, but these studies often use global measures and rarely focus on early development when psychopathology commonly emerges. To address this, we combined high-resolution air pollution exposure estimates and prospectively-collected phenotypic data to explore concurrent and longitudinal associations between air pollutants of major concern in urban areas and mental health problems in childhood and adolescence. Exploratory analyses were conducted on 284 London-based children from the Environmental Risk (E-Risk) Longitudinal Twin Study. Exposure to annualized PM2.5 and NO2 concentrations was estimated at address-level when children were aged 12. Symptoms of anxiety, depression, conduct disorder, and attention-deficit hyperactivity disorder were assessed at ages 12 and 18. Psychiatric diagnoses were ascertained from interviews with the participants at age 18. We found no associations between age-12 pollution exposure and concurrent mental health problems. However, age-12 pollution estimates were significantly associated with increased odds of major depressive disorder at age 18, even after controlling for common risk factors. This study demonstrates the potential utility of incorporating high-resolution pollution estimates into large epidemiological cohorts to robustly investigate associations between air pollution and youth mental health.

1 June 2019 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
JNJoanne B. Newbury
Joanne B. Newbury
LALouise Arseneault
Louise Arseneault
SBSean Beevers
Sean Beevers
NKNutthida Kitwiroon
Nutthida Kitwiroon
SRSusanna Roberts
Susanna Roberts
HFHelen L. Fisher
Helen L. Fisher
Several decades have passed since Faris and Dunham1 first documented higher rates of schizophrenia in inner-city Chicago relative to the city outskirts. The body of research since their ecological study suggests that urban upbringing is associated with a 2-fold adulthood risk for psychotic disorder.2 Given that 70% of the world’s population will be urban by 2050,3 uncovering the mechanisms linking the urban environment to psychosis and developing preventive interventions constitute an urgent health priority.

1 June 2015 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
JHJennifer L. Hudson
Jennifer L. Hudson
RKRobert Keers
Robert Keers
SRSusanna Roberts
Susanna Roberts
Jonathan ColemanJonathan Coleman
Jonathan Coleman
GBGerome Breen
Gerome Breen
TEThalia C. Eley
Thalia C. Eley
The Genes for Treatment study is an international, multisite collaboration exploring the role of genetic, demographic, and clinical predictors in response to cognitive-behavioral therapy (CBT) in pediatric anxiety disorders. The current article, the first from the study, examined demographic and clinical predictors of response to CBT. We hypothesized that the child's gender, type of anxiety disorder, initial severity and comorbidity, and parents' psychopathology would significantly predict outcome. A sample of 1,519 children 5 to 18 years of age with a primary anxiety diagnosis received CBT across 11 sites. Outcome was defined as response (change in diagnostic severity) and remission (absence of the primary diagnosis) at each time point (posttreatment, 3-, 6-, and/or 12-month follow-up) and analyzed using linear and logistic mixed models. Separate analyses were conducted using data from posttreatment and follow-up assessments to explore the relative importance of predictors at these time points. Individuals with social anxiety disorder (SoAD) had significantly poorer outcomes (poorer response and lower rates of remission) than those with generalized anxiety disorder (GAD). Although individuals with specific phobia (SP) also had poorer outcomes than those with GAD at posttreatment, these differences were not maintained at follow-up. Both comorbid mood and externalizing disorders significantly predicted poorer outcomes at posttreatment and follow-up, whereas self-reported parental psychopathology had little effect on posttreatment outcomes but significantly predicted response (although not remission) at follow-up. SoAD, nonanxiety comorbidity, and parental psychopathology were associated with poorer outcomes after CBT. The results highlight the need for enhanced treatments for children at risk for poorer outcomes.

1 April 2016 in Psychotherapy and Psychosomatics
Verified
Journal Article
Open access
PDF file
RKRobert Keers
Robert Keers
Jonathan ColemanJonathan Coleman
Jonathan Coleman
KLKathryn J. Lester
Kathryn J. Lester
SRSusanna Roberts
Susanna Roberts
GBGerome Breen
Gerome Breen
TEThalia C. Eley
Thalia C. Eley
Background: The differential susceptibly hypothesis suggests that certain genetic variants moderate the effects of both negative and positive environments on mental health and may therefore be important predictors of response to psychological treatments. Nevertheless, the identification of such variants has so far been limited to preselected candidate genes. In this study we extended the differential susceptibility hypothesis from a candidate gene to a genome-wide approach to test whether a polygenic score of environmental sensitivity predicted response to cognitive behavioural therapy (CBT) in children with anxiety disorders. Methods: We identified variants associated with environmental sensitivity using a novel method in which within-pair variability in emotional problems in 1,026 monozygotic twin pairs was examined as a function of the pairs' genotype. We created a polygenic score of environmental sensitivity based on the whole-genome findings and tested the score as a moderator of parenting on emotional problems in 1,406 children and response to individual, group and brief parent-led CBT in 973 children with anxiety disorders. Results: The polygenic score significantly moderated the effects of parenting on emotional problems and the effects of treatment. Individuals with a high score responded significantly better to individual CBT than group CBT or brief parent-led CBT (remission rates: 70.9, 55.5 and 41.6%, respectively). Conclusions: Pending successful replication, our results should be considered exploratory. Nevertheless, if replicated, they suggest that individuals with the greatest environmental sensitivity may be more likely to develop emotional problems in adverse environments but also benefit more from the most intensive types of treatment.

7 October 2015 in Depression and Anxiety
Verified
Journal Article
Open access
PDF file
SRSusanna Roberts
Susanna Roberts
RKRobert Keers
Robert Keers
KLKathryn J Lester
Kathryn J Lester
Jonathan ColemanJonathan Coleman
Jonathan Coleman
GBGerome Breen
Gerome Breen
CWChloe C. Y. Wong
Chloe C. Y. Wong
Hypothalamic–pituitary–adrenal (HPA) axis functioning has been implicated in the development of stress-related psychiatric diagnoses and response to adverse life experiences. This study aimed to investigate the association between genetic and epigenetics in HPA axis and response to cognitive behavior therapy (CBT). Children with anxiety disorders were recruited into the Genes for Treatment project (GxT, N = 1,152). Polymorphisms of FKBP5 and GR were analyzed for association with response to CBT. Percentage DNA methylation at the FKBP5 and GR promoter regions was measured before and after CBT in a subset (n = 98). Linear mixed effect models were used to investigate the relationship between genotype, DNA methylation, and change in primary anxiety disorder severity (treatment response). Treatment response was not associated with FKBP5 and GR polymorphisms, or pretreatment percentage DNA methylation. However, change in FKBP5 DNA methylation was nominally significantly associated with treatment response. Participants who demonstrated the greatest reduction in severity decreased in percentage DNA methylation during treatment, whereas those with little/no reduction in severity increased in percentage DNA methylation. This effect was driven by those with one or more FKBP5 risk alleles, with no association seen in those with no FKBP5 risk alleles. No significant association was found between GR methylation and response. Allele-specific change in FKBP5 methylation was associated with treatment response. This is the largest study to date investigating the role of HPA axis related genes in response to a psychological therapy. Furthermore, this is the first study to demonstrate that DNA methylation changes may be associated with response to psychological therapies in a genotype-dependent manner.

18 June 2013 in Journal of Child Psychology and Psychiatry
Verified
Journal Article
Open access
PDF file
JHJennifer L. Hudson
Jennifer L. Hudson
KLKathryn J. Lester
Kathryn J. Lester
CLCathryn Lewis
Cathryn Lewis
MTMaria Tropeano
Maria Tropeano
CCCathy Creswell
Cathy Creswell
TEThalia C. Eley
Thalia C. Eley
Background: Within a therapeutic gene by environment (G × E) framework, we recently demonstrated that variation in the Serotonin Transporter Promoter Polymorphism; 5 HTTLPR and marker rs6330 in Nerve Growth Factor gene; NGF is associated with poorer outcomes following cognitive behaviour therapy ( CBT ) for child anxiety disorders. The aim of this study was to explore one potential means of extending the translational reach of G × E data in a way that may be clinically informative. We describe a ‘risk‐index’ approach combining genetic, demographic and clinical data and test its ability to predict diagnostic outcome following CBT in anxious children. Method: DNA and clinical data were collected from 384 children with a primary anxiety disorder undergoing CBT . We tested our risk model in five cross‐validation training sets. Results: In predicting treatment outcome, six variables had a minimum mean beta value of 0.5:5 HTTLPR , NGF rs6330, gender, primary anxiety severity, comorbid mood disorder and comorbid externalising disorder. A risk index (range 0–8) constructed from these variables had moderate a predictive ability ( AUC = .62–.69) in this study. Children scoring high on this index (5–8) were approximately three times as likely to retain their primary anxiety disorder at follow‐up as compared with those children scoring 2 or less. Conclusion: Significant genetic, demographic and clinical predictors of outcome following CBT for anxiety‐disordered children were identified. Combining these predictors within a risk index could be used to identify which children are less likely to be diagnosis‐free following CBT alone and require longer or enhanced treatment. The ‘risk‐index’ approach represents one means of harnessing the translational potential of G × E data.